NLS Pharmaceutics Ltd NLSP 深 沪
等待开盘 08-06 09:30:00 美东时间
1.86
-0.027
-1.43%
华盛通- 最 高2.00
- 今 开1.88
- 成交量 6.10万股
- 最 低 1.81
- 昨 收 1.887
- 总市值 669.15万
- 52周最高 7.44
- 市盈率 静 --
- 换手率 1.70%
- 52周最低 1.30
- 委 比 56.74%
- 总股本 359.76万
- 历史最高 294.00
- 量 比 1.15
- 振 幅 10.07%
- 历史最低 1.30
- 每 手 1
- 风险率 1.78%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多NLS Pharma's Diabetes Treatment Project Gets Fresh Funding Boost From US-Israel Foundation
NLS Pharmaceutics Ltd. (NASDAQ:NLSP) ("NLS"), a Swiss clinical-stage biopharmaceutical company focused on central nervous system disorders, today announced that the Israel-U.S. Binational Industrial Research and
07-17 19:02
Why Greenbrier Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Shares of The Greenbrier Companies, Inc. (NYSE: GBX) rose sharply in today's pre-market trading after the company posted stronger-than-expected results for the third quarter. The company posted quarterly earnings of $1.86 per share, beating market estimates of 98 cents per share.
07-02 17:55
NLS Pharmaceutics Gains Shareholder Approval for Strategic Agenda
NLS Pharmaceutics ( ($NLSP) ) just unveiled an update. On June 30, 2025, NLS Ph...
07-02 04:56
NLS Pharmaceutics Extends Merger Agreement with Kadimastem
An announcement from NLS Pharmaceutics ( ($NLSP) ) is now available. On July 1,...
07-02 04:28
NLS Pharmaceutics and Kadimastem Announce Pricing and Closing of $1 Million Equity Financing
Accumulated proceeds of $3 million including the initial closing held in March 2025 ZÜRICH, June 30, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP) ("NLS" or the "Company"), a Sw...
06-30 19:00
NLS Pharmaceutics CEO Issues Letter to Shareholders
ZURICH , June 16, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP), a Swiss clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous ...
06-16 19:00
NLS Pharmaceutics Extends Merger Agreement with Kadimastem
The latest update is out from NLS Pharmaceutics ( ($NLSP) ). On May 5, 2025, NL...
05-06 04:27
NLS Pharmaceutics Announces Board Resignation Amid Restructuring Efforts
NLS Pharmaceutics ( ($NLSP) ) has provided an update. On April 18, 2025, Audrey...
04-25 04:28
NLS Pharmaceutics Reports Positive Results in Fentanyl Study
The latest update is out from NLS Pharmaceutics ( ($NLSP) ). On April 15, 2025,...
04-15 21:27
NLS Pharmaceutics Secures $3 Million Financing and $25 Million Equity Facility
An update from NLS Pharmaceutics ( ($NLSP) ) is now available. NLS Pharmaceutic...
03-31 21:45
